CALR and cancer: In past, others and we have demonstrated that, naturally occurring or artificially-induced, defects in ecto-CALR exposure, ATP secretion or HMGB1 release can cause cancer cells to resist the pro-immunogenic effects of ICD [25, 26, 28, 45–48].